Show an ad over header. AMP

I am the FIRST

Pro-McConnell PAC to challenge Trump’s primary endorsements

A super PAC closely aligned with Senate Minority Leader Mitch McConnell (R-Ky.) is prepared to intervene in GOP primaries — and challenge former President Trump — as it looks for the most viable candidates to reclaim the Senate.

Driving the news: Trump’s weekend endorsement of Rep. Ted Budd (R-N.C.) in his state's 2022 Senate race put the GOP establishment on notice that party leaders won’t necessarily get to handpick their preferred candidates for the crucial midterms.


  • Trump and McConnell, former allies, parted ways over the former president's challenge to the 2020 election results and his speech stoking the Jan. 6 insurrection.
  • In some cases, Trump and GOP strategists may agree on who the best candidate is, but the pro-McConnell PAC — the Senate Leadership Fund — also is making clear it will make its own, independent assessment.
  • “As has long been SLF’s policy, we reserve the right to intervene in cases where a candidate is a clear threat to lose a seat in a general election and to protect our Republican incumbents,” Jack Pandol, the PAC's communications director, told Axios.

Why it matters: Candidate selection will be crucial to Republican efforts next year, given the 50-50 split in the Senate and GOP retirements in North Carolina, Pennsylvania, Ohio, Missouri and Alabama.

  • McConnell has a personal interest in the outcome, since victory would allow him to regain control of the Senate agenda.
  • The National Republican Senatorial Committee, led by Sen. Rick Scott (R-Fla.), has indicated it won’t intervene in open primaries and focus instead on softening up the likely Democratic nominee.
  • “The NRSC has no interest spending any time or money attacking other Republicans,” said Chris Hartline, the NRSC's communications director. “We started Day 1 defining Democrats across the country as the ultra-liberal, big-spending, open borders radicals that they are.”

Flashback: The NRSC did take an interventionist approach in Kansas in 2020 and helped guide their preferred candidate, now-Sen. Roger Marshall, through a winding primary.

  • The Democratic Senatorial Campaign Committee also has long taken an interventionist approach and refuses to apologize for trying to clear the field in favor of its favored candidates.

Between the lines: Scott has asked the former president to stay neutral in primaries.

  • Trump’s North Carolina endorsement, as well as his attacks on Arizona Attorney General Mark Brnovich, who is contemplating his own Senate run, suggest Trump has other plans.
  • In Missouri, the GOP establishment is concerned that former Gov. Eric Greitens, who resigned from office in 2018 after being indicted, could get a nod from Trump.
  • It's unclear, though, if Greitens would be an obvious loser in the general election, especially in a state Trump won by 15 points.

Go deeper: Democrats plan to exploit the Republican internal battles.

  • “In North Carolina — and across the Senate map — Trump is escalating GOP primaries and making the Republican infighting even worse,” said David Bergstein, the communications director for the DSCC.

Be smart: Trump’s Budd endorsement in North Carolina hasn’t cleared the field, and two other candidates — former Gov. Pat McCrory and former Rep. Mark Walker — show no sign of abandoning the race.

4 ffp

Why the startup world needs to ditch "unicorns" for "dragons"

When Aileen Lee originally coined the term "unicorn" in late 2013, she was describing the 39 "U.S.-based software companies started since 2003 and valued at over $1 billion by public or private market investors."

Flashback: It got redefined in early 2015 by yours truly and Erin Griffith, in a cover story for Fortune, as any privately-held startup valued at $1 billion or more. At the time, we counted 80 of them.

Keep reading... Show less

Scoop: Facebook's new moves to lower News Feed's political volume

Facebook plans to announce that it will de-emphasize political posts and current events content in the News Feed based on negative user feedback, Axios has learned. It also plans to expand tests to limit the amount of political content that people see in their News Feeds to more countries outside of the U.S.

Why it matters: The changes could reduce traffic to some news publishers, particularly companies that post a lot of political content.

Keep reading... Show less

Scoop: Amazon quietly getting into live audio business

Amazon is investing heavily in a new live audio feature that's similar to other live audio offerings like Clubhouse, Twitter Spaces and Spotify's new live audio platform, sources tell Axios.

Why it matters: As with Amazon's efforts in podcasting and music subscriptions, the company sees live audio as a way to bolster the types of content it can offer through its voice assistant, Alexa, and its smart speaker products.

Keep reading... Show less

Hurricane Ida exposes America's precarious energy infrastructure

The powerful hurricane that plunged New Orleans into darkness for what could be weeks is the latest sign that U.S. power systems are not ready for a warmer, more volatile world.

The big picture: “Our current infrastructure is not adequate when it comes to these kinds of weather extremes,” Joshua Rhodes, a University of Texas energy expert, tells Axios.

Keep reading... Show less

"We must go further": 70% of adults in European Union are fully vaccinated

About 70% of adults in the European Union are fully vaccinated against COVID-19, Ursula von der Leyen, the president of the European Commission, said Tuesday.

Why it matters: The milestone makes the E.U. one of the world's leaders in inoculations, after an initially lagging vaccine campaign, the New York Times notes.

Keep reading... Show less

What Elizabeth Holmes jurors will be asked ahead of fraud trial

Jury selection begins today in USA v. Elizabeth Holmes, with the actual jury trial to get underway on Sept. 8.

Why it matters: Theranos was the biggest fraud in Silicon Valley history, putting both hundreds of millions of dollars and thousands of patients' health at risk.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories